Women's Health

The FDA approved cefepime and zidebactam (Zaynich, Wockhardt), a novel intravenous antibiotic, for adults with complicated urinary tract infections, including pyelonephritis, caused by susceptible...

The FDA approved cefepime and zidebactam (Zaynich, Wockhardt), a novel intravenous antibiotic, for adults with complicated urinary tract infections, including pyelonephritis, caused by susceptible...

The FDA approved cefepime and zidebactam (Zaynich, Wockhardt), a novel intravenous antibiotic, for adults with complicated urinary tract infections, including pyelonephritis, caused by susceptible...

The FDA approved cefepime and zidebactam (Zaynich, Wockhardt), a novel intravenous antibiotic, for adults with complicated urinary tract infections, including pyelonephritis, caused by susceptible...

The FDA approved cefepime and zidebactam (Zaynich, Wockhardt), a novel intravenous antibiotic, for adults with complicated urinary tract infections, including pyelonephritis, caused by susceptible...

FDA approval gives physicians the first authorized treatment option for adults with chronic hepatitis delta virus infection.

FDA approval gives physicians the first authorized treatment option for adults with chronic hepatitis delta virus infection.

FDA approval gives physicians the first authorized treatment option for adults with chronic hepatitis delta virus infection.

FDA approval gives physicians the first authorized treatment option for adults with chronic hepatitis delta virus infection.

FDA approval gives physicians the first authorized treatment option for adults with chronic hepatitis delta virus infection.